Publications from OUS - Skin- and head and neck cancer

95 publications found

Publications 2024

1. Huynh TM, Falk RS, Hellebust TP, Dale E, Astrup GL, Hjermstad MJ, Malinen E, Bjordal K, Kiserud CE, Herlofson BB, Nome R, Amdal CD (2024)
   Chronic fatigue in long-term survivors of head and neck cancer treated with radiotherapy
   Radiother Oncol, 195, 110231 (in press)
   DOI 10.1016/j.radonc.2024.110231, PubMed 38518958
2. Kristensen MH, Holm AIS, Hansen CR, Zukauskaite R, Samsøe E, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Overgaard J, Eriksen JG (2024)
   High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma - A DAHANCA 19 study
   Clin Transl Radiat Oncol, 46, 100772
   DOI 10.1016/j.ctro.2024.100772, PubMed 38596816
3. Kristensen MH, Sørensen MK, Tramm T, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Lilja-Fischer JK, Holm AIS, Samsøe E, Hansen CR, Zukauskaite R, Overgaard J, Eriksen JG (2024)
   Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - A DAHANCA 19 study
   Radiother Oncol, 193, 110149
   DOI 10.1016/j.radonc.2024.110149, PubMed 38341096
4. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2024)
   Long-term health-related quality of life in head and neck cancer survivors: A large multinational study
   Int J Cancer, 154 (10), 1772-1785
   DOI 10.1002/ijc.34861, PubMed 38312044

Publications 2023

1. Amdal CD, Moan JM, Dale E, Falk RS, Johansen S, Bjordal K (2023)
   Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study
   Clin Transl Radiat Oncol, 42, 100654
   DOI 10.1016/j.ctro.2023.100654, PubMed 37415638
2. Bratland Å, Munoz-Couselo E, Mortier L, Roshdy O, González R, Schachter J, Arance AM, Grange F, Meyer N, Joshi AJ, Billan S, Hughes BGM, Grob JJ, Ramakrishnan K, Ge J, Gumuscu B, Swaby RF, Gutzmer R (2023)
   Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
   Dermatol Ther (Heidelb), 13 (12), 3165-3180
   DOI 10.1007/s13555-023-01059-y, PubMed 37943491
3. Garset-Zamani M, von Buchwald C, Karevold G, Agander TK, Mateu-Regué À, Eide HA, Tvedskov JF (2023)
   An HPV-Vaccinated Patient With Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
   JAMA Otolaryngol Head Neck Surg, 149 (1), 92-94
   DOI 10.1001/jamaoto.2022.3762, PubMed 36416857
4. Groendahl AR, Huynh BN, Tomic O, Søvik Å, Dale E, Malinen E, Skogmo HK, Futsaether CM (2023)
   Automatic gross tumor segmentation of canine head and neck cancer using deep learning and cross-species transfer learning
   Front Vet Sci, 10, 1143986
   DOI 10.3389/fvets.2023.1143986, PubMed 37026102
5. Harrington KJ, Ferris RL, Gillison M, Tahara M, Argiris A, Fayette J, Schenker M, Bratland Å, Walker JWT, Grell P, Even C, Chung CH, Redman R, Coutte A, Salas S, Grant C, de Azevedo S, Soulières D, Hansen AR, Wei L, Khan TA, Miller-Moslin K, Roberts M, Haddad R (2023)
   Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial
   JAMA Oncol, 9 (6), 779-789
   DOI 10.1001/jamaoncol.2023.0147, PubMed 37022706
6. Huynh BN, Groendahl AR, Tomic O, Liland KH, Knudtsen IS, Hoebers F, van Elmpt W, Malinen E, Dale E, Futsaether CM (2023)
   Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics
   Front Med (Lausanne), 10, 1217037
   DOI 10.3389/fmed.2023.1217037, PubMed 37711738
7. Huynh TM, Dale E, Falk RS, Hellebust TP, Astrup GL, Malinen E, Edin NFJ, Bjordal K, Herlofson BB, Kiserud CE, Helland Å, Amdal CD (2023)
   Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters
   Radiother Oncol, 190, 110044
   DOI 10.1016/j.radonc.2023.110044, PubMed 38061420
8. Liu L, Choi J, Musoro JZ, Sauerbrei W, Amdal CD, Alanya A, Barbachano Y, Cappelleri JC, Falk RS, Fiero MH, Regnault A, Reijneveld JC, Sandin R, Thomassen D, Roychoudhury S, Goetghebeur E, le Cessie S, SISAQOL-IMI Work Package 3 (2023)
   Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice
   Lancet Oncol, 24 (5), e197-e206
   DOI 10.1016/S1470-2045(23)00110-9, PubMed 37142381
9. Pe M, Alanya A, Falk RS, Amdal CD, Bjordal K, Chang J, Cislo P, Coens C, Dirven L, Speck RM, Fitzgerald K, Galinsky J, Giesinger JM, Holzner B, Le Cessie S, O'Connor D, Oliver K, Pawar V, Quinten C, Schlichting M, Ren J, Roychoudhury S, Taphoorn MJB, Velikova G, Wintner LM et al. (2023)
   Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
   Lancet Oncol, 24 (6), e270-e283
   DOI 10.1016/S1470-2045(23)00157-2, PubMed 37269858
10. Richartz N, Pietka W, Yadav A, Bostad M, Bhagwat S, Naderi S, Naderi EH, Stokke T, Ruud E, Blomhoff HK (2023)
    N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells
    J Biol Chem, 300 (1), 105509
    DOI 10.1016/j.jbc.2023.105509, PubMed 38042493
11. Rohde M, Eriksen JG, Pareek M, Bratland Å, Mäkitie A, Hammarstedt-Nordenvall L, Wessel I, Lybeck JS, Mäenpää H, Gebre-Medhin M, Godballe C (2023)
    Diagnosis of locally recurrent head and neck squamous cell carcinoma in the Nordic HNC centers and feasibility of the Odense-Birmingham definition
    Acta Oncol, 62 (9), 1102-1105
    DOI 10.1080/0284186X.2023.2245550, PubMed 37602835
12. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2023)
    Serious Long-Term Effects of Head and Neck Cancer from the Survivors' Point of View
    Healthcare (Basel), 11 (6)
    DOI 10.3390/healthcare11060906, PubMed 36981562
13. Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
    Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
    Crit Care, 27 (1), 9
    DOI 10.1186/s13054-022-04205-8, PubMed 36627655

Publications 2022

1. Amdal CD, Falk RS, Singer S, Pe M, Piccinin C, Bottomley A, Appiah LT, Arraras JI, Bayer O, Buanes EA, Darlington AS, Arbanas GD, Hofsø K, Holzner B, Sahlstrand-Johnson P, Kuliś D, Parmar G, Rmeileh NMEA, Schranz M, Sodergren S, Bjordal K (2022)
   A multicenter international prospective study of the validity and reliability of a COVID-19-specific health-related quality of life questionnaire
   Qual Life Res, 32 (2), 447-459
   DOI 10.1007/s11136-022-03272-2, PubMed 36273365
2. Amdal CD, Taylor K, Kuliś D, Falk RS, Bottomley A, Arraras JI, Barte JH, Darlington AS, Hofsø K, Holzner B, Jørgensen NMH, Mariano MP, Pe M, Piccinin C, Riccetti N, Schranz M, Wheelwright S, Bjordal K (2022)
   Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure
   J Patient Rep Outcomes, 6 (1), 26
   DOI 10.1186/s41687-022-00434-1, PubMed 35348945
3. Burtness B, Rischin D, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Brana I, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Ge J, Swaby RF, Gumuscu B, Harrington K (2022)
   Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
   J Clin Oncol, 40 (21), 2321-2332
   DOI 10.1200/JCO.21.02198, PubMed 35333599
4. Evensen ME, Furre T, Malinen E, Løndalen AM, Dale E (2022)
   Mucosa-sparing dose painting of head and neck cancer
   Acta Oncol, 61 (2), 141-145
   DOI 10.1080/0284186X.2021.2022200, PubMed 34991431
5. Harrington KJ, Burtness B, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Brana I, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Lin J, Gumuscu B, Swaby RF, Rischin D (2022)
   Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
   J Clin Oncol, 41 (4), 790-802
   DOI 10.1200/JCO.21.02508, PubMed 36219809
6. Huynh TTM, Aass HCD, Falk RS, Astrup GL, Helland Å, Bjøro T, Bjordal K, Dale E, Hellebust TP, Herlofson BB, Malinen E, Kiserud CE, Osnes T, Amdal CD (2022)
   Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy
   J Cancer Surviv, 17 (4), 1082-1093
   DOI 10.1007/s11764-022-01273-1, PubMed 36350483
7. Hynne H, Aqrawi LA, Jensen JL, Thiede B, Palm Ø, Amdal CD, Westgaard KL, Herlofson BB, Utheim TP, Galtung HK (2022)
   Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients
   Int J Mol Sci, 23 (7)
   DOI 10.3390/ijms23073714, PubMed 35409074
8. Ivanova A, Rodríguez-Cano R, Kvalem IL, Harcourt D, Kiserud CE, Amdal CD (2022)
   Body image concerns in long-term head and neck cancer survivors: prevalence and role of clinical factors and patient-reported late effects
   J Cancer Surviv, 17 (2), 526-534
   DOI 10.1007/s11764-022-01311-y, PubMed 36509859
9. Nyrud MK, Bratland Å, Landrø L, Brevig T, Ryder T, Hermann R, Frich L (2022)
   Merkel cell carcinoma
   Tidsskr Nor Laegeforen, 142 (9)
   DOI 10.4045/tidsskr.21.0693, PubMed 35699540
10. Richartz N, Pietka W, Gilljam KM, Skah S, Skålhegg BS, Bhagwat S, Naderi EH, Ruud E, Blomhoff HK (2022)
    cAMP-Mediated Autophagy Promotes Cell Survival via ROS-Induced Activation of PARP1: Implications for Treatment of Acute Lymphoblastic Leukemia
    Mol Cancer Res, 20 (3), 400-411
    DOI 10.1158/1541-7786.MCR-21-0652, PubMed 34880123
11. Rischin D, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Braña I, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Ishak WZW, Hong RL, Mendoza RG, Jia L, Chirovsky D, Norquist J, Jin F, Burtness B (2022)
    Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
    Oral Oncol, 128, 105815
    DOI 10.1016/j.oraloncology.2022.105815, PubMed 35381576

Publications 2021

1. Amdal CD, Pe M, Falk RS, Piccinin C, Bottomley A, Arraras JI, Darlington AS, Hofsø K, Holzner B, Jørgensen NMH, Kulis D, Rimehaug SA, Singer S, Taylor K, Wheelwright S, Bjordal K (2021)
   Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review
   Qual Life Res, 30 (12), 3367-3381
   DOI 10.1007/s11136-021-02908-z, PubMed 34146226
2. Chen X, Badian RA, Hynne H, Amdal CD, Herlofson BB, Utheim ØA, Westgaard KL, Fineide F, Jensen JL, Utheim TP (2021)
   Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer
   Sci Rep, 11 (1), 22419
   DOI 10.1038/s41598-021-01844-9, PubMed 34789830
3. Groendahl AR, Skjei Knudtsen I, Huynh BN, Mulstad M, Moe YM, Knuth F, Tomic O, Indahl UG, Torheim T, Dale E, Malinen E, Futsaether CM (2021)
   A comparison of methods for fully automatic segmentation of tumors and involved nodes in PET/CT of head and neck cancers
   Phys Med Biol, 66 (6), 065012
   DOI 10.1088/1361-6560/abe553, PubMed 33666176
4. Moe YM, Groendahl AR, Tomic O, Dale E, Malinen E, Futsaether CM (2021)
   Deep learning-based auto-delineation of gross tumour volumes and involved nodes in PET/CT images of head and neck cancer patients
   Eur J Nucl Med Mol Imaging, 48 (9), 2782-2792
   DOI 10.1007/s00259-020-05125-x, PubMed 33559711
5. Singer S, Hammerlid E, Tomaszewska IM, Amdal CD, Bjordal K, Herlofson BB, Santos M, Silva JC, Mehanna H, Fullerton A, Brannan C, Gonzalez LF, Inhestern J, Pinto M, Arraras JI, Yarom N, Bonomo P, Baumann I, Galalae R, Nicolatou-Galitis O, Kiyota N, Raber-Durlacher J, Salem D, Fabian A, Boehm A et al. (2021)
   Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
   Qual Life Res, 31 (3), 841-853
   DOI 10.1007/s11136-021-02939-6, PubMed 34272632
6. Westgaard KL, Hynne H, Amdal CD, Young A, Singh PB, Chen X, Rykke M, Hove LH, Aqrawi LA, Utheim TP, Herlofson BB, Jensen JL (2021)
   Oral and ocular late effects in head and neck cancer patients treated with radiotherapy
   Sci Rep, 11 (1), 4026
   DOI 10.1038/s41598-021-83635-w, PubMed 33597629
7. Wright P, Arnesen MR, Lønne PI, Suilamo S, Silvoniemi A, Dale E, Minn H, Malinen E (2021)
   Repeatability of hypoxia dose painting by numbers based on EF5-PET in head and neck cancer
   Acta Oncol, 60 (11), 1386-1391
   DOI 10.1080/0284186X.2021.1944663, PubMed 34184605

Publications 2020

1. Abravan A, Eide HA, Helland Å, Malinen E (2020)
   Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
   Clin Transl Radiat Oncol, 22, 15-21
   DOI 10.1016/j.ctro.2020.02.005, PubMed 32181373
2. Aqrawi LA, Chen X, Hynne H, Amdal C, Reppe S, Aass HCD, Rykke M, Hove LH, Young A, Herlofson BB, Westgaard KL, Utheim TP, Galtung HK, Jensen JL (2020)
   Cytokines Explored in Saliva and Tears from Radiated Cancer Patients Correlate with Clinical Manifestations, Influencing Important Immunoregulatory Cellular Pathways
   Cells, 9 (9)
   DOI 10.3390/cells9092050, PubMed 32911805
3. Brandal P, Bergfeldt K, Aggerholm-Pedersen N, Bäckström G, Kerna I, Gubanski M, Björnlinger K, Evensen ME, Kuddu M, Pettersson E, Brydøy M, Hellebust TP, Dale E, Valdman A, Weber L, Høyer M (2020)
   A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients
   Acta Oncol, 59 (10), 1157-1163
   DOI 10.1080/0284186X.2020.1817977, PubMed 32902341
4. Hauge T, Amdal CD, Falk RS, Johannessen HO, Johnson E (2020)
   Long-term outcome in patients operated with hybrid esophagectomy for esophageal cancer - a cohort study
   Acta Oncol, 59 (7), 859-865
   DOI 10.1080/0284186X.2020.1750694, PubMed 32324079
5. König M, Osnes T, Bruland Ø, Sundby Hall K, Bratland Å, Meling TR (2020)
   The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review
   Front Oncol, 10, 1402
   DOI 10.3389/fonc.2020.01402, PubMed 32850452
6. Witt Nyström P, Bratland Å, Minn H, Grau C (2020)
   Ongoing and future clinical trials in particle therapy in the Nordic countries
   Acta Oncol, 59 (10), 1145-1150
   DOI 10.1080/0284186X.2020.1792548, PubMed 32673134

Publications 2019

1. Abravan A, Eide HA, Løndalen AM, Helland Å, Malinen E (2019)
   Mapping Bone Marrow Response in the Vertebral Column by Positron Emission Tomography Following Radiotherapy and Erlotinib Therapy of Lung Cancer
   Mol Imaging Biol, 21 (2), 391-398
   DOI 10.1007/s11307-018-1226-7, PubMed 29916117
2. Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D, KEYNOTE-048 Investigators (2019)
   Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
   Lancet, 394 (10212), 1915-1928
   DOI 10.1016/S0140-6736(19)32591-7, PubMed 31679945
3. König M, Osnes T, Bratland Å, Jebsen P, Meling TR (2019)
   Treatment of Sinonasal Adenocarcinoma: A Population-Based Prospective Cohort Study
   J Neurol Surg B Skull Base, 81 (6), 627-637
   DOI 10.1055/s-0039-1694050, PubMed 33381366
4. König M, Osnes T, Bratland Å, Meling TR (2019)
   Squamous Cell Carcinoma of the Paranasal Sinuses: A Single Center Experience
   J Neurol Surg B Skull Base, 81 (6), 664-672
   DOI 10.1055/s-0039-1694967, PubMed 33381371
5. Moan JM, Amdal CD, Malinen E, Svestad JG, Bogsrud TV, Dale E (2019)
   The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status
   Radiother Oncol, 140, 54-61
   DOI 10.1016/j.radonc.2019.05.019, PubMed 31177043
6. Richartz N, Duthil E, Ford A, Naderi EH, Bhagwat S, Gilljam KM, Burman MM, Ruud E, Blomhoff HK, Skah S (2019)
   Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model
   Blood Adv, 3 (21), 3181-3190
   DOI 10.1182/bloodadvances.2019000473, PubMed 31698450
7. Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, Santos M, Inhestern J, Brannan C, Yarom N, Fullerton A, Pinto M, Arraras JI, Kiyota N, Bonomo P, Sherman AC, Baumann I, Galalae R, Fernandez Gonzalez L, Nicolatou-Galitis O, Abdel-Hafeez Z, Raber-Durlacher J, Schmalz C, Zotti P, Boehm A et al. (2019)
   International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV
   Head Neck, 41 (6), 1725-1737
   DOI 10.1002/hed.25609, PubMed 30636188

Publications 2018

1. Dale E, Waldeland E (2018)
   Proton therapy - a reality in Norway from 2023
   Tidsskr Nor Laegeforen, 138 (13)
   DOI 10.4045/tidsskr.18.0250, PubMed 30180494
2. Eide HA, Knudtsen IS, Sandhu V, Løndalen AM, Halvorsen AR, Abravan A, Kure EH, Bogsrud TV, Brustugun OT, Kyte JA, Malinen E, Helland Å (2018)
   Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
   Adv Radiat Oncol, 3 (2), 130-138
   DOI 10.1016/j.adro.2017.12.007, PubMed 29904737
3. Enden T, Bernklev T, Jelsness-Jorgensen LP, Amdal CD (2018)
   Patients know their own health best
   Tidsskr. Nor. Laegeforen., 138 (8), 716-718
4. Skah S, Richartz N, Duthil E, Gilljam KM, Bindesbøll C, Naderi EH, Eriksen AB, Ruud E, Dirdal MM, Simonsen A, Blomhoff HK (2018)
   cAMP-mediated autophagy inhibits DNA damage-induced death of leukemia cells independent of p53
   Oncotarget, 9 (54), 30434-30449
   DOI 10.18632/oncotarget.25758, PubMed 30100998
5. Skjøtskift T, Evensen ME, Furre T, Moan JM, Amdal CD, Bogsrud TV, Malinen E, Dale E (2018)
   Dose painting for re-irradiation of head and neck cancer
   Acta Oncol, 57 (12), 1693-1699
   DOI 10.1080/0284186X.2018.1512753, PubMed 30280623

Publications 2017

1. Abravan A, Eide HA, Knudtsen IS, Løndalen AM, Helland Å, Malinen E (2017)
   Assessment of pulmonary ¹⁸F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib
   Clin Transl Radiat Oncol, 4, 57-63
   DOI 10.1016/j.ctro.2017.04.002, PubMed 29594209
2. Abravan A, Knudtsen IS, Eide HA, Løndalen AM, Helland Å, van Luijk P, Malinen E (2017)
   A new method to assess pulmonary changes using ¹⁸F-fluoro-2-deoxyglucose positron emission tomography for lung cancer patients following radiotherapy
   Acta Oncol, 56 (11), 1597-1603
   DOI 10.1080/0284186X.2017.1349336, PubMed 28849707
3. Amdal CD, Jacobsen AB, Falk RS, Johnson E, Os SS, Warloe T, Bjordal K (2017)
   Improved treatment decisions in patients with esophageal cancer
   Acta Oncol, 56 (10), 1286-1294
   DOI 10.1080/0284186X.2017.1346379, PubMed 28686501
4. Johansen S, Norman MH, Dale E, Amdal CD, Furre T, Malinen E, Evensen JF (2017)
   Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer
   Radiat Oncol, 12 (1), 87
   DOI 10.1186/s13014-017-0829-5, PubMed 28545588
5. Mikalsen LTG, Arnesen MR, Bogsrud TV, Dale E, Stokke C (2017)
   Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancer
   Acta Oncol, 56 (6), 894-897
   DOI 10.1080/0284186X.2017.1286384, PubMed 28464741
6. Mäkitie AA, Cange HH, Hammarstedt-Nordenvall L, Gudjonsson A, Jóhannsson J, Laranne J, Mäenpää H, Rikardsen O, Bratland Å, Wessel I, Johansen J, Grau C (2017)
   Head and neck cancer management in the Nordic countries: an effort to harmonize treatment
   Eur Arch Otorhinolaryngol, 274 (5), 2363-2365
   DOI 10.1007/s00405-017-4456-4, PubMed 28124110

Publications 2016

1. Dale E, Moan JM, Osnes TA, Bogsrud TV (2016)
   Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome
   Eur Arch Otorhinolaryngol, 274 (2), 1015-1019
   DOI 10.1007/s00405-016-4318-5, PubMed 27671150
2. Eide HA, Halvorsen AR, Bjaanæs MM, Piri H, Holm R, Solberg S, Jørgensen L, Brustugun OT, Kiserud CE, Helland Å (2016)
   The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypes
   BMC Cancer, 16, 71
   DOI 10.1186/s12885-016-2104-9, PubMed 26858029
3. Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T (2016)
   Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
   Eur Heart J, 37 (21), 1671-80
   DOI 10.1093/eurheartj/ehw022, PubMed 26903532

Publications 2015

1. Arnesen MR, Knudtsen IS, Rekstad BL, Eilertsen K, Dale E, Bruheim K, Helland Å, Løndalen AM, Hellebust TP, Malinen E (2015)
   Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps
   Acta Oncol, 54 (9), 1607-13
   DOI 10.3109/0284186X.2015.1061690, PubMed 26213311

Publications 2014

1. Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fosså SD (2014)
   Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery
   J Cancer Surviv, 9 (2), 172-9
   DOI 10.1007/s11764-014-0399-6, PubMed 25216609
2. Dale E (2014)
   [Re: Brachytherapy for malignant uveal melanoma]
   Tidsskr Nor Laegeforen, 134 (8), 814
   DOI 10.4045/tidsskr.14.0467, PubMed 24780973
3. Eikesdal HP, Løes S, Herlofson BB (2014)
   [Dental health when using bisphosphonates against breast cancer]
   Tidsskr Nor Laegeforen, 134 (15), 1451
   DOI 10.4045/tidsskr.14.0717, PubMed 25138400
4. von der Lippe C, Roscher I, Nordgarden H, Rustad C, Larsen SM, Mjøen E, Bratland Å (2014)
   Man with macrocephaly, learning disability and multiple basal cell carcinomas
   Tidsskr Nor Laegeforen, 134 (11), 1151-4
   DOI 10.4045/tidsskr.13.0894, PubMed 24939783

Publications 2013

1. Amdal CD, Jacobsen AB, Sandstad B, Warloe T, Bjordal K (2013)
   Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial
   Radiother Oncol, 107 (3), 428-33
   DOI 10.1016/j.radonc.2013.04.008, PubMed 23647761
2. Dahl S, Steinsvik EA, Dahl AA, Loge JH, Cvancarova M, Fosså SD (2013)
   Return to work and sick leave after radical prostatectomy: a prospective clinical study
   Acta Oncol, 53 (6), 744-51
   DOI 10.3109/0284186X.2013.844357, PubMed 24195691
3. Gulati G, Heck SL, Ree AH, Gravdehaug B, Røsjø H, Steine K, Bratland Å, Hoffmann P, Geisler J, Omland T (2013)
   [Cardioprotective treatment during adjuvant cancer therapy]
   Tidsskr Nor Laegeforen, 133 (17), 1832-6
   DOI 10.4045/tidsskr.12.1514, PubMed 24042297
4. Krüger TB, Sharikabad MN, Herlofson BB (2013)
   Bisphosphonate-related osteonecrosis of the jaw in four Nordic countries and an indication of under-reporting
   Acta Odontol Scand, 71 (6), 1386-90
   DOI 10.3109/00016357.2013.764007, PubMed 23351164
5. Røe K, Bratland Å, Vlatkovic L, Ragnum HB, Saelen MG, Olsen DR, Marignol L, Ree AH (2013)
   Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer
   PLoS One, 8 (5), e63723
   DOI 10.1371/journal.pone.0063723, PubMed 23675504

Publications 2012

1. Amdal CD, Jacobsen AB, Guren MG, Bjordal K (2012)
   Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review
   Acta Oncol, 52 (4), 679-90
   DOI 10.3109/0284186X.2012.731521, PubMed 23190360
2. Heck SL, Gulati G, Ree AH, Schulz-Menger J, Gravdehaug B, Røsjø H, Steine K, Bratland A, Hoffmann P, Geisler J, Omland T (2012)
   Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial
   Cardiology, 123 (4), 240-7
   DOI 10.1159/000343622, PubMed 23207160
3. Hjermstad MJ, Bergenmar M, Fisher SE, Montel S, Nicolatou-Galitis O, Raber-Durlacher J, Singer S, Verdonck-de Leeuw I, Weis J, Yarom N, Herlofson BB (2012)
   The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients
   Eur J Cancer, 48 (14), 2203-11
   DOI 10.1016/j.ejca.2012.04.003, PubMed 22572480
4. Khullar SM, Tvedt D, Chapman K, Herlofson BB (2012)
   Sixty cases of extreme osteonecrosis and osteomyelitis of the mandible and maxilla in a West African population
   Int J Oral Maxillofac Surg, 41 (8), 978-85
   DOI 10.1016/j.ijom.2012.04.022, PubMed 22652445
5. Wilberg P, Hjermstad MJ, Ottesen S, Herlofson BB (2012)
   Oral health is an important issue in end-of-life cancer care
   Support Care Cancer, 20 (12), 3115-22
   DOI 10.1007/s00520-012-1441-8, PubMed 22434497

Publications 2011

1. Amdal CD, Jacobsen AB, Tausjø JE, Wiig JN, Warloe T, Sandstad B, Bjordal K (2011)
   Palliative interventions and prognosis in patients with advanced esophageal cancer
   Dis Esophagus, 24 (7), 502-9
   DOI 10.1111/j.1442-2050.2010.01174.x, PubMed 21309923

Publications 2010

1. Dale E, Hårsaker V, Kristoffersen DT, Bruland O, Olsen DR (2010)
   CT density in lung cancer patients after radiotherapy sensitized by metoclopramide. A subgroup analysis of a randomized trial
   Strahlenther Onkol, 186 (3), 163-8
   DOI 10.1007/s00066-010-2040-6, PubMed 20165821
2. Wranicz P, Herlofson BB, Evensen JF, Kongsgaard UE (2010)
   Prevention and treatment of trismus in head and neck cancer: A case report and a systematic review of the literature
   Scand J Pain, 1 (2), 84-88
   DOI 10.1016/j.sjpain.2010.01.006, PubMed 29913945

Publications 2008

1. Ree AH, Bratland A, Dueland S (2008)
   [Molecular targeted therapy in colorectal cancer]
   Tidsskr Nor Laegeforen, 128 (2), 190-3
   PubMed 18202731

Publications 2006

1. Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y (2006)
   DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting
   Anticancer Res, 26 (3A), 1909-16
   PubMed 16827124
2. Steinsvoll S, Herlofson BB (2006)
   [Oral manifestations in HIV infection]
   Tidsskr Nor Laegeforen, 126 (9), 1218-21
   PubMed 16670745

Publications 2005

1. Kolseth I, Herlofson BB, Pedersen A (2005)
   Norwegian LongoVital and recurrent aphthous ulceration: a randomized, double-blind, placebo-controlled study
   Oral Dis, 11 (6), 374-8
   DOI 10.1111/j.1601-0825.2005.01133.x, PubMed 16269029
2. Nome RV, Bratland A, Harman G, Fodstad O, Andersson Y, Ree AH (2005)
   Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death
   Mol Cancer Ther, 4 (8), 1231-8
   DOI 10.1158/1535-7163.MCT-04-0304, PubMed 16093439

Publications 2004

1. DeMasters GA, Gupta MS, Jones KR, Cabot M, Wang H, Gennings C, Park M, Bratland A, Ree AH, Gewirtz DA (2004)
   Potentiation of cell killing by fractionated radiation and suppression of proliferative recovery in MCF-7 breast tumor cells by the Vitamin D3 analog EB 1089
   J Steroid Biochem Mol Biol, 92 (5), 365-74
   DOI 10.1016/j.jsbmb.2004.07.011, PubMed 15698541
2. Ree AH, Bratland A, Nome RV, Stokke T, Fodstad O, Andersson Y (2004)
   Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization?
   Radiother Oncol, 72 (3), 305-10
   DOI 10.1016/j.radonc.2004.07.002, PubMed 15450729
3. Ree AH, Bratland A, Solberg Landsverk K, Fodstad O (2004)
   Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner
   Anticancer Res, 24 (2B), 555-62
   PubMed 15160994

Publications 2003

1. Lilleby W, Dale E, Olsen DR, Gude U, Fosså SD (2003)
   Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose
   Acta Oncol, 42 (1), 10-4
   DOI 10.1080/0891060310002177, PubMed 12665325
2. Ree AH, Bratland A, Nome RV, Stokke T, Fodstad Ø (2003)
   Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1
   Oncogene, 22 (55), 8952-5
   DOI 10.1038/sj.onc.1207000, PubMed 14654792

Publications 2002

1. Dale E (2002)
   [Updated when it comes to the prevention of restenosis?]
   Tidsskr Nor Laegeforen, 122 (17), 1720; author reply 1720
   PubMed 12555618
2. Johannessen HO, Dale E, Hellebust TP, Olsen DR, Nesland JM, Giercksky KE (2002)
   Modeling volume effects of experimental brachytherapy in the rat rectum: uncovering the limitations of a radiobiologic concept
   Int J Radiat Oncol Biol Phys, 53 (4), 1014-22
   DOI 10.1016/s0360-3016(02)02835-3, PubMed 12095571
3. Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM (2002)
   Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases
   Anticancer Res, 22 (4), 1949-57
   PubMed 12174869

Publications 1996

1. Skaare AB, Herlofson BB, Barkvoll P (1996)
   Mouthrinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU)
   J Clin Periodontol, 23 (8), 778-81
   DOI 10.1111/j.1600-051x.1996.tb00609.x, PubMed 8877665

Publications 1994

1. Røed A, Herlofson BB (1994)
   Inhibitory effects of HgCl2 on excitation-secretion coupling at the motor nerve terminal and excitation-contraction coupling in the muscle cell
   Cell Mol Neurobiol, 14 (6), 623-36
   DOI 10.1007/BF02088672, PubMed 7543823